These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28490751)

  • 41. Cell-Selective Adeno-Associated Virus-Mediated
    Tanenhaus A; Stowe T; Young A; McLaughlin J; Aeran R; Lin IW; Li J; Hosur R; Chen M; Leedy J; Chou T; Pillay S; Vila MC; Kearney JA; Moorhead M; Belle A; Tagliatela S
    Hum Gene Ther; 2022 Jun; 33(11-12):579-597. PubMed ID: 35435735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A functional null mutation of SCN1B in a patient with Dravet syndrome.
    Patino GA; Claes LR; Lopez-Santiago LF; Slat EA; Dondeti RS; Chen C; O'Malley HA; Gray CB; Miyazaki H; Nukina N; Oyama F; De Jonghe P; Isom LL
    J Neurosci; 2009 Aug; 29(34):10764-78. PubMed ID: 19710327
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adolescent behavioral abnormalities in a Scn1a
    Bahceci D; Anderson LL; Occelli Hanbury Brown CV; Zhou C; Arnold JC
    Epilepsy Behav; 2020 Feb; 103(Pt A):106842. PubMed ID: 31870807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preictal dysfunctions of inhibitory interneurons paradoxically lead to their rebound hyperactivity and to low-voltage-fast onset seizures in Dravet syndrome.
    Capitano F; Kuchenbuch M; Lavigne J; Chaptoukaev H; Zuluaga MA; Lorenzi M; Nabbout R; Mantegazza M
    Proc Natl Acad Sci U S A; 2024 Jun; 121(23):e2316364121. PubMed ID: 38809712
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tau reduction prevents disease in a mouse model of Dravet syndrome.
    Gheyara AL; Ponnusamy R; Djukic B; Craft RJ; Ho K; Guo W; Finucane MM; Sanchez PE; Mucke L
    Ann Neurol; 2014 Sep; 76(3):443-56. PubMed ID: 25042160
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice.
    Hawkins NA; Jurado M; Thaxton TT; Duarte SE; Barse L; Tatsukawa T; Yamakawa K; Nishi T; Kondo S; Miyamoto M; Abrahams BS; During MJ; Kearney JA
    Epilepsia; 2021 Nov; 62(11):2845-2857. PubMed ID: 34510432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aberrant regulation of a poison exon caused by a non-coding variant in a mouse model of Scn1a-associated epileptic encephalopathy.
    Voskobiynyk Y; Battu G; Felker SA; Cochran JN; Newton MP; Lambert LJ; Kesterson RA; Myers RM; Cooper GM; Roberson ED; Barsh GS
    PLoS Genet; 2021 Jan; 17(1):e1009195. PubMed ID: 33411788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome.
    Ricobaraza A; Bunuales M; Gonzalez-Aparicio M; Fadila S; Rubinstein M; Vides-Urrestarazu I; Banderas J; Sola-Sevilla N; Sanchez-Carpintero R; Lanciego JL; Roda E; Honrubia A; Arnaiz P; Hernandez-Alcoceba R
    J Mol Med (Berl); 2023 Dec; 101(12):1587-1601. PubMed ID: 37819378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene expression profiling in a mouse model of Dravet syndrome.
    Hawkins NA; Calhoun JD; Huffman AM; Kearney JA
    Exp Neurol; 2019 Jan; 311():247-256. PubMed ID: 30347190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nav1.1 haploinsufficiency in excitatory neurons ameliorates seizure-associated sudden death in a mouse model of Dravet syndrome.
    Ogiwara I; Iwasato T; Miyamoto H; Iwata R; Yamagata T; Mazaki E; Yanagawa Y; Tamamaki N; Hensch TK; Itohara S; Yamakawa K
    Hum Mol Genet; 2013 Dec; 22(23):4784-804. PubMed ID: 23922229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome.
    Cheah CS; Westenbroek RE; Roden WH; Kalume F; Oakley JC; Jansen LA; Catterall WA
    Channels (Austin); 2013; 7(6):468-72. PubMed ID: 23965409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic partial TrkB activation reduces seizures and mortality in a mouse model of Dravet syndrome.
    Gu F; Parada I; Yang T; Longo FM; Prince DA
    Proc Natl Acad Sci U S A; 2022 Feb; 119(7):. PubMed ID: 35165147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Altered cardiac electrophysiology and SUDEP in a model of Dravet syndrome.
    Auerbach DS; Jones J; Clawson BC; Offord J; Lenk GM; Ogiwara I; Yamakawa K; Meisler MH; Parent JM; Isom LL
    PLoS One; 2013; 8(10):e77843. PubMed ID: 24155976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proteomic signature of the Dravet syndrome in the genetic Scn1a-A1783V mouse model.
    Miljanovic N; Hauck SM; van Dijk RM; Di Liberto V; Rezaei A; Potschka H
    Neurobiol Dis; 2021 Sep; 157():105423. PubMed ID: 34144125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathy.
    Estacion M; O'Brien JE; Conravey A; Hammer MF; Waxman SG; Dib-Hajj SD; Meisler MH
    Neurobiol Dis; 2014 Sep; 69():117-23. PubMed ID: 24874546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel rat model of Dravet syndrome recapitulates clinical hallmarks.
    Li M; Yang L; Qian W; Ray S; Lu Z; Liu T; Zou YY; Naumann RK; Wang H
    Neurobiol Dis; 2023 Aug; 184():106193. PubMed ID: 37295561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A high seizure burden increases several prostaglandin species in the hippocampus of a Scn1a
    Zhou C; Satpute V; Yip KL; Anderson LL; Hawkins N; Kearney J; Arnold JC
    Prostaglandins Other Lipid Mediat; 2024 Jun; 172():106836. PubMed ID: 38599513
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential Inhibition of Human Nav1.2 Resurgent and Persistent Sodium Currents by Cannabidiol and GS967.
    Mason ER; Cummins TR
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32244818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hippocampal deletion of Na
    Stein RE; Kaplan JS; Li J; Catterall WA
    Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16571-16576. PubMed ID: 31346088
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy.
    Martin MS; Tang B; Papale LA; Yu FH; Catterall WA; Escayg A
    Hum Mol Genet; 2007 Dec; 16(23):2892-9. PubMed ID: 17881658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.